Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $17.70 USD
Change Today -0.06 / -0.34%
Volume 265.8K
AEGR On Other Exchanges
As of 8:10 PM 09/4/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Marc D. Beer

AgeTotal Calculated CompensationThis person is connected to 46 board members in 4 different organizations across 8 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Marc D. Beer served as the Chief Executive Officer at Aegerion Pharmaceuticals, Inc. from August 19, 2010 to July 27, 2015. Mr. Beer founded ViaCell, Inc., and served as its President and Chief Executive Officer from April 2000 to November 2007. From April 1996 to 2000, he held marketing and business development roles at Genzyme Corporation, Sanofi pharmaceutical company, served as Vice President of Global Marketing. From 1996 to April 2000, he served as Senior Manager ...

Read Full Background

Corporate Headquarters*

One Main Street
Cambridge, Massachusetts 02142

United States

Phone: 617-500-7867
Fax: 617-945-7968

Board Members Memberships*

Chairman of The Board
Chairman, Chairman of Compensation Committee and Member of Audit Committee


Miami University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$635,000

Stock Options*

All Other Compensation$46,811
Exercised Options9,400
Exercisable Options1,057,456
Exercisable Options Value$15,367,756
Unexercisable Options175,417
Unexercisable Options Value$137,680
Total Value of Options$15,505,436
Total Number of Options1,449,773

Total Compensation*

Total Annual Cash Compensation$681,811
Total Short Term Compensation$635,000
Other Long Term Compensation$46,811
Total Calculated Compensation$4,198,531
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AEGR:US $17.70 USD -0.06


Stanley T. Crooke M.D., Ph.D.Founder, Executive Chairman, Chief Executive Officer, President, Chairman of Science/Medical Committee and Member of Agenda Committee
Isis Pharmaceuticals, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AEGERION PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at